State of Alaska Department of Revenue Sells 4,964 Shares of The Clorox Company (NYSE:CLX)

State of Alaska Department of Revenue trimmed its position in The Clorox Company (NYSE:CLX - Free Report) by 26.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,115 shares of the company's stock after selling 4,964 shares during the period. State of Alaska Department of Revenue's holdings in Clorox were worth $2,292,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vision Capital Management Inc. acquired a new stake in shares of Clorox during the 4th quarter valued at $201,000. Money Concepts Capital Corp lifted its position in shares of Clorox by 3.3% during the 4th quarter. Money Concepts Capital Corp now owns 22,056 shares of the company's stock valued at $3,582,000 after acquiring an additional 697 shares during the last quarter. Lion Street Advisors LLC lifted its position in shares of Clorox by 10.0% during the 4th quarter. Lion Street Advisors LLC now owns 5,294 shares of the company's stock valued at $860,000 after acquiring an additional 480 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Clorox by 21.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,508 shares of the company's stock valued at $3,013,000 after acquiring an additional 3,249 shares during the last quarter. Finally, Verity Asset Management Inc. lifted its position in shares of Clorox by 8.4% during the 4th quarter. Verity Asset Management Inc. now owns 3,110 shares of the company's stock valued at $501,000 after acquiring an additional 241 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 1.9 %

Clorox stock traded down $2.86 during mid-day trading on Friday, hitting $147.91. 1,318,065 shares of the company's stock were exchanged, compared to its average volume of 1,333,562. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The stock has a market cap of $18.31 billion, a P/E ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a 50 day moving average of $159.55 and a two-hundred day moving average of $159.13.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 EPS. As a group, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. JPMorgan Chase & Co. increased their price objective on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Royal Bank of Canada reissued a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and boosted their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.